Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Ram Seetharaman who wrote (1704)	3/1/2000 6:43:00 PM
From: yosid	Read Replies (1) \| Respond to of 1754

There are a few things that come to mind when I think of VISX: The company is fundamentally sound and has lots of cash. The company has lots of patents in an area where the dominant player will generate significant revenue. They are under siege by quick buck artist, speculators, and attorneys trying to cash in on the potentials in the laser markets. Every manufacturer with a new laser has to find a way into that market, or die on the vine. The near future for the company lies in the hands of the patent grantors. If the ITC positively rules for VISX next week, that will be the beginning of a turnaround that will see a better share price evolve. If the US Patent Office reissues various basic patents in their favor, VISX (and Summit) will be the gatekeepers, and collect a royalty on just about every procedure performed in the USA. Until this shakes out, we are all speculating as to the growth of this company.